Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.7850
+0.1059 (15.59%)
At close: Oct 9, 2025, 4:00 PM EDT
0.7170
-0.0680 (-8.66%)
Pre-market: Oct 10, 2025, 5:48 AM EDT

RVPH Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-27.11-29.92-39.26-28.26-8.52-3.78
Upgrade
Depreciation & Amortization
-----0
Upgrade
Stock-Based Compensation
2.221.633.410.180.15-
Upgrade
Other Adjustments
-0.13-0.720.240.19-1.592.05
Upgrade
Changes in Accounts Payable
-0.092.290.333.01-0.50.78
Upgrade
Changes in Accrued Expenses
-2.03-5.146.884.611.51-0.77
Upgrade
Changes in Other Operating Activities
0.6-1.690.071.31-1.71-2.33
Upgrade
Operating Cash Flow
-26.55-33.54-28.32-18.96-10.67-4.07
Upgrade
Short-Term Debt Issued
-0.980.67---
Upgrade
Short-Term Debt Repaid
-0.66-0.52-0.67---
Upgrade
Net Short-Term Debt Issued (Repaid)
-0.660.46----
Upgrade
Long-Term Debt Issued
-----3.11
Upgrade
Net Long-Term Debt Issued (Repaid)
-----3.11
Upgrade
Issuance of Common Stock
-23.1933.177.7931.60.34
Upgrade
Net Common Stock Issued (Repurchased)
-23.1933.177.7931.60.34
Upgrade
Other Financing Activities
-----9.38
Upgrade
Financing Cash Flow
30.7323.6533.177.7931.612.83
Upgrade
Net Cash Flow
4.19-9.894.85-11.1720.938.76
Upgrade
Beginning Cash & Cash Equivalents
6.1823.3718.5229.698.760
Upgrade
Ending Cash & Cash Equivalents
10.3613.4823.3718.5229.698.76
Upgrade
Free Cash Flow
-26.55-33.54-28.32-18.96-10.67-4.07
Upgrade
Free Cash Flow Per Share
-0.62-1.01-1.19-0.97-0.72-1.33
Upgrade
Levered Free Cash Flow
-29.29-34-31.98-19.33-9.22-3
Upgrade
Unlevered Free Cash Flow
-28.9-35.36-32.24-19.28-10.81-4.76
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q